Cell-Type-Specific Quantification of a Scaffold-Based 3D Liver Co-Culture

被引:9
作者
Ruoss, Marc [1 ]
Kieber, Vanessa [1 ]
Rebholz, Silas [1 ]
Linnemann, Caren [1 ]
Rinderknecht, Helen [1 ]
Haeussling, Victor [1 ]
Haecker, Marina [1 ]
Damink, Leon H. H. Olde [2 ]
Ehnert, Sabrina [1 ]
Nussler, Andreas K. [1 ]
机构
[1] Eberhard Karls Univ Tubingen, BG Klin Tubingen, Siegfried Weller Inst, Dept Traumatol, D-72076 Tubingen, Germany
[2] Matricel GmbH, D-52134 Herzogenrath, Germany
关键词
quantification; 3D culture; co-culture; cell number; PCR-based method; STEM-CELLS; ALAMAR BLUE; PROLIFERATION; ASSAY; CULTURE; HEPATOCYTES; VIABILITY; GROWTH; 2D; FIBROBLASTS;
D O I
10.3390/mps3010001
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
In order to increase the metabolic activity of human hepatocytes and liver cancer cell lines, many approaches have been reported in recent years. The metabolic activity could be increased mainly by cultivating the cells in 3D systems or co-cultures (with other cell lines). However, if the system becomes more complex, it gets more difficult to quantify the number of cells (e.g., on a 3D matrix). Until now, it has been impossible to quantify different cell types individually in 3D co-culture systems. Therefore, we developed a PCR-based method that allows the quantification of HepG2 cells and 3T3-J2 cells separately in a 3D scaffold culture. Moreover, our results show that this method allows better comparability between 2D and 3D cultures in comparison to the often-used approaches based on metabolic activity measurements, such as the conversion of resazurin.
引用
收藏
页码:1 / 19
页数:19
相关论文
共 63 条
  • [11] The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance
    Breslin, Susan
    O'Driscoll, Lorraine
    [J]. ONCOTARGET, 2016, 7 (29) : 45745 - 45756
  • [12] Meeting the Challenge of Predicting Hepatic Clearance of Compounds Slowly Metabolized by Cytochrome P450 Using a Novel Hepatocyte Model, HepatoPac
    Chan, Tom S.
    Yu, Hongbin
    Moore, Amanda
    Khetani, Salman R.
    Tweedie, Donald
    [J]. DRUG METABOLISM AND DISPOSITION, 2013, 41 (12) : 2024 - 2032
  • [13] A new technique for primary hepatocyte expansion in vitro
    Cho, Chenl H.
    Berthiaume, Francois
    Tilles, Arno W.
    Yarmush, Martin L.
    [J]. BIOTECHNOLOGY AND BIOENGINEERING, 2008, 101 (02) : 345 - 356
  • [14] Collagen scaffold microenvironments modulate cell lineage commitment for differentiation of bone marrow cells into regulatory dendritic cells
    Fang, Yongxiang
    Wang, Bin
    Zhao, Yannan
    Xiao, Zhifeng
    Li, Jing
    Cui, Yi
    Han, Sufang
    Wei, Jianshu
    Chen, Bing
    Han, Jin
    Meng, Qingyuan
    Hou, Xianglin
    Luo, Jianxun
    Dai, Jianwu
    Jing, Zhizhong
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [15] HepG2 and human healthy hepatocyte in vitro culture and coculture in PCL electrospun platforms
    Fasolino, I.
    Guarino, V.
    Marrese, M.
    Cirillo, V.
    Vallifuoco, M.
    Tamma, M. L.
    Vassallo, V.
    Bracco, A.
    Calise, F.
    Ambrosio, L.
    [J]. BIOMEDICAL MATERIALS, 2018, 13 (01)
  • [16] Flow Cytometric Cell Cycle Analysis of Muscle Precursor Cells Cultured Within 3D Scaffolds in a Perfusion Bioreactor
    Flaibani, Marina
    Luni, Camilla
    Sbalchiero, Elisa
    Elvassore, Nicola
    [J]. BIOTECHNOLOGY PROGRESS, 2009, 25 (01) : 286 - 295
  • [17] Characterization of a functional C3A liver spheroid model
    Gaskell, Harriet
    Sharma, Parveen
    Colley, Helen E.
    Murdoch, Craig
    Williams, Dominic P.
    Webb, Steven D.
    [J]. TOXICOLOGY RESEARCH, 2016, 5 (04) : 1053 - 1065
  • [18] Glicklis R, 2000, BIOTECHNOL BIOENG, V67, P344, DOI 10.1002/(SICI)1097-0290(20000205)67:3<344::AID-BIT11>3.0.CO
  • [19] 2-2
  • [20] Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME
    Godoy, Patricio
    Hewitt, Nicola J.
    Albrecht, Ute
    Andersen, Melvin E.
    Ansari, Nariman
    Bhattacharya, Sudin
    Bode, Johannes Georg
    Bolleyn, Jennifer
    Borner, Christoph
    Boettger, Jan
    Braeuning, Albert
    Budinsky, Robert A.
    Burkhardt, Britta
    Cameron, Neil R.
    Camussi, Giovanni
    Cho, Chong-Su
    Choi, Yun-Jaie
    Rowlands, J. Craig
    Dahmen, Uta
    Damm, Georg
    Dirsch, Olaf
    Teresa Donato, Maria
    Dong, Jian
    Dooley, Steven
    Drasdo, Dirk
    Eakins, Rowena
    Ferreira, Karine Sa
    Fonsato, Valentina
    Fraczek, Joanna
    Gebhardt, Rolf
    Gibson, Andrew
    Glanemann, Matthias
    Goldring, Chris E. P.
    Jose Gomez-Lechon, Maria
    Groothuis, Geny M. M.
    Gustavsson, Lena
    Guyot, Christelle
    Hallifax, David
    Hammad, Seddik
    Hayward, Adam
    Haeussinger, Dieter
    Hellerbrand, Claus
    Hewitt, Philip
    Hoehme, Stefan
    Holzhuetter, Hermann-Georg
    Houston, J. Brian
    Hrach, Jens
    Ito, Kiyomi
    Jaeschke, Hartmut
    Keitel, Verena
    [J]. ARCHIVES OF TOXICOLOGY, 2013, 87 (08) : 1315 - 1530